Table of Contents 1 Market Overview 1.1 Duchenne Muscular Dystrophy Introduction 1.2 Market Analysis by Type 1.2.1 Deflazacort 1.2.2 Prednisone 1.2.3 Others 1.3 Market Analysis by Applications 1.3.1 Male 1.3.2 Female 1.4 Market Analysis by Countries 1.4.1 China Status and Prospect (2013-2023) 1.4.2 Korea Status and Prospect (2013-2023) 1.4.3 Japan Status and Prospect (2013-2023) 1.4.4 Taiwan Status and Prospect (2013-2023) 1.4.5 Southeast Asia Status and Prospect (2013-2023) 1.4.6 India Status and Prospect (2013-2023) 1.4.7 Australia Status and Prospect (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 PTC Therapeutics 2.1.1 Business Overview 2.1.2 Duchenne Muscular Dystrophy Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Sarepta Therapeutics 2.2.1 Business Overview 2.2.2 Duchenne Muscular Dystrophy Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Bristol-Myers Squibb 2.3.1 Business Overview 2.3.2 Duchenne Muscular Dystrophy Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 ITALFARMACO 2.4.1 Business Overview 2.4.2 Duchenne Muscular Dystrophy Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 ITALFARMACO Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 BioMarin 2.5.1 Business Overview 2.5.2 Duchenne Muscular Dystrophy Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 BioMarin Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Daiichi Sankyo 2.6.1 Business Overview 2.6.2 Duchenne Muscular Dystrophy Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Daiichi Sankyo Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Solid Biosciences 2.7.1 Business Overview 2.7.2 Duchenne Muscular Dystrophy Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Solid Biosciences Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Summit Therapeutics 2.8.1 Business Overview 2.8.2 Duchenne Muscular Dystrophy Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Summit Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 FibroGen 2.9.1 Business Overview 2.9.2 Duchenne Muscular Dystrophy Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 FibroGen Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 NS Pharma 2.10.1 Business Overview 2.10.2 Duchenne Muscular Dystrophy Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 NS Pharma Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Pfizer 2.11.1 Business Overview 2.11.2 Duchenne Muscular Dystrophy Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 Pfizer Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 ReveraGen BioPharma 2.12.1 Business Overview 2.12.2 Duchenne Muscular Dystrophy Type and Applications 2.12.2.1 Type 1 2.12.2.2 Type 2 2.12.3 ReveraGen BioPharma Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Wave Life 2.13.1 Business Overview 2.13.2 Duchenne Muscular Dystrophy Type and Applications 2.13.2.1 Type 1 2.13.2.2 Type 2 2.13.3 Wave Life Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Genethon 2.14.1 Business Overview 2.14.2 Duchenne Muscular Dystrophy Type and Applications 2.14.2.1 Type 1 2.14.2.2 Type 2 2.14.3 Genethon Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 Santhera Pharmaceuticals 2.15.1 Business Overview 2.15.2 Duchenne Muscular Dystrophy Type and Applications 2.15.2.1 Type 1 2.15.2.2 Type 2 2.15.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Asia-Pacific Duchenne Muscular Dystrophy Market Competition, by Manufacturer 3.1 Asia-Pacific Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2016-2017) 3.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2016-2017) 3.2.1 Asia-Pacific Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017) 3.2.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer (2016-2017) 3.3 Asia-Pacific Duchenne Muscular Dystrophy Price by Manufacturers (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Duchenne Muscular Dystrophy Manufacturer Market Share (2016-2017) 3.4.2 Top 6 Duchenne Muscular Dystrophy Manufacturer Market Share (2016-2017) 3.5 Market Competition Trend 4 Asia-Pacific Duchenne Muscular Dystrophy Market Analysis by Countries/Regions 4.1 Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Countries/Regions 4.2 Asia-Pacific Duchenne Muscular Dystrophy Sales by Countries/Regions (2013-2018) 4.2.1 Asia-Pacific Duchenne Muscular Dystrophy Sales by Countries/Regions (2013-2018) 4.2.2 Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Countries (2013-2018) 4.3 Asia-Pacific Duchenne Muscular Dystrophy Revenue (Value) by Countries (2013-2018) 4.3.1 Asia-Pacific Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018) 4.3.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Countries (2013-2018) 5 Asia-Pacific Market Segmentation Duchenne Muscular Dystrophy by Type 5.1 Asia-Pacific Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Type (2013-2018) 5.1.1 Asia-Pacific Duchenne Muscular Dystrophy Sales and Market Share by Type (2013-2018) 5.1.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue and Market Share by Type (2013-2018) 5.2 Type 1 Sales Growth Rate and Price (2013-2018) 5.2.1 Asia-Pacific Type 1 Sales Growth Rate (2013-2018) 5.2.2 Asia-Pacific Type 1 Price (2013-2018) 5.3 Type 2 Sales Growth Rate and Price (2013-2018) 5.3.1 Asia-Pacific Type 2 Sales Growth Rate (2013-2018) 5.3.2 Asia-Pacific Type 2 Price (2013-2018) 5.4 Type 3 Sales Growth Rate and Price (2013-2018) 5.4.1 Asia-Pacific Type 3 Sales Growth Rate (2013-2018) 5.4.2 Asia-Pacific Type 3 Price (2013-2018) 5.5 Type 4 Sales Growth Rate and Price (2013-2018) 5.5.1 Asia-Pacific Type 4 Sales Growth Rate (2013-2018) 5.5.2 Asia-Pacific Type 4 Price (2013-2018) 5.6 Type 5 Sales Growth Rate and Price (2013-2018) 5.6.1 Asia-Pacific Type 5 Sales Growth Rate (2013-2018) 5.6.2 Asia-Pacific Type 5 Price (2013-2018) 6 Asia-Pacific Market Segmentation Duchenne Muscular Dystrophy by Application 6.1 Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) 6.2 Male Sales Growth (2013-2018) 6.3 Female Sales Growth (2013-2018) 7 China Duchenne Muscular Dystrophy Sales, Revenue, by Type, Application and Manufacturers 7.1 China Duchenne Muscular Dystrophy Revenue, Sales and Growth Rate (2013-2018) 7.2 China Duchenne Muscular Dystrophy Sales and Market Share by Type (2013-2018) 7.2.1 China Duchenne Muscular Dystrophy Sales by Type (2013-2018) 7.2.2 China Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) 7.3 China Duchenne Muscular Dystrophy Sales and Market Share by Application (2013-2018) 7.3.1 China Duchenne Muscular Dystrophy Sales by Application (2013-2018) 7.3.2 China Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) 7.4 China Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Manufacturer (2016-2017) 7.4.1 China Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2016-2017) 7.4.2 China Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2016-2017) 7.5 China Duchenne Muscular Dystrophy Export and Import (2013-2018) 8 Japan Duchenne Muscular Dystrophy Sales, Revenue, by Type, Application and Manufacturers 8.1 Japan Duchenne Muscular Dystrophy Revenue, Sales and Growth Rate (2013-2018) 8.2 Japan Duchenne Muscular Dystrophy Sales and Market Share by Type (2016-2017) 8.2.1 Japan Duchenne Muscular Dystrophy Sales by Type (2013-2018) 8.2.2 Japan Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) 8.3 Japan Duchenne Muscular Dystrophy Sales and Market Share by Application (2013-2018) 8.3.1 Japan Duchenne Muscular Dystrophy Sales by Application (2013-2018) 8.3.2 Japan Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) 8.4 Japan Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Manufacturer (2016-2017) 8.4.1 Japan Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2016-2017) 8.4.2 Japan Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2016-2017) 8.5 Japan Duchenne Muscular Dystrophy Export and Import (2013-2018) 9 Korea Duchenne Muscular Dystrophy Sales, Revenue, by Type, Application and Manufacturers 9.1 Korea Duchenne Muscular Dystrophy Revenue, Sales and Growth Rate (2013-2018) 9.2 Korea Duchenne Muscular Dystrophy Sales and Market Share by Type (2013-2018) 9.2.1 Korea Duchenne Muscular Dystrophy Sales by Type (2013-2018) 9.2.2 Korea Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) 9.3 Korea Duchenne Muscular Dystrophy Sales and Market Share by Application (2013-2018) 9.3.1 Korea Duchenne Muscular Dystrophy Sales by Application (2013-2018) 9.3.2 Korea Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) 9.4 Korea Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Manufacturer (2016-2017) 9.4.1 Korea Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2016-2017) 9.4.2 Korea Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2016-2017) 9.5 Korea Duchenne Muscular Dystrophy Export and Import (2013-2018) 10 Taiwan Duchenne Muscular Dystrophy Sales, Revenue, by Type, Application and Manufacturers 10.1 Taiwan Duchenne Muscular Dystrophy Revenue, Sales and Growth Rate (2013-2018) 10.2 Taiwan Duchenne Muscular Dystrophy Sales and Market Share by Type (2013-2018) 10.2.1 Taiwan Duchenne Muscular Dystrophy Sales by Type (2013-2018) 10.2.2 Taiwan Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) 10.3 Taiwan Duchenne Muscular Dystrophy Sales and Market Share by Application (2013-2018) 10.3.1 Taiwan Duchenne Muscular Dystrophy Sales by Application (2013-2018) 10.3.2 Taiwan Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) 10.4 Taiwan Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Manufacturer (2016-2017) 10.4.1 Taiwan Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2016-2017) 10.4.2 Taiwan Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2016-2017) 10.5 Taiwan Duchenne Muscular Dystrophy Export and Import (2013-2018) 11 Southeast Asia Duchenne Muscular Dystrophy Sales, Revenue, by Type, Application and Manufacturers 11.1 Southeast Asia Duchenne Muscular Dystrophy Revenue, Sales and Growth Rate (2013-2018) 11.2 Southeast Asia Duchenne Muscular Dystrophy Sales and Market Share by Type (2013-2018) 11.2.1 Southeast Asia Duchenne Muscular Dystrophy Sales by Type (2013-2018) 11.2.2 Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) 11.3 Southeast Asia Duchenne Muscular Dystrophy Sales by Application (2013-2018) 11.3.1 Southeast Asia Duchenne Muscular Dystrophy Sales by Application (2013-2018) 11.3.2 Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) 11.4 Southeast Asia Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Manufacturer (2016-2017) 11.4.1 Southeast Asia Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2016-2017) 11.4.2 Southeast Asia Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer 11.5 Southeast Asia Duchenne Muscular Dystrophy Export and Import (2013-2018) 12 India Duchenne Muscular Dystrophy Sales, Revenue, by Type, Application and Manufacturers 12.1 India Duchenne Muscular Dystrophy Revenue, Sales and Growth Rate (2013-2018) 12.2 India Duchenne Muscular Dystrophy Sales and Market Share by Type (2013-2018) 12.2.1 India Duchenne Muscular Dystrophy Sales by Type (2013-2018) 12.2.2 India Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) 12.3 India Duchenne Muscular Dystrophy Sales and Market Share by Application (2013-2018) 12.3.1 India Duchenne Muscular Dystrophy Sales by Application (2013-2018) 12.3.2 India Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) 12.4 India Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Manufacturer (2016-2017) 12.4.1 India Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2016-2017) 12.4.2 India Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2016-2017) 12.5 India Duchenne Muscular Dystrophy Export and Import (2013-2018) 13 Australia Duchenne Muscular Dystrophy Sales, Revenue, by Type, Application and Manufacturers 13.1 Australia Duchenne Muscular Dystrophy Revenue, Sales and Growth Rate (2013-2018) 13.2 Australia Duchenne Muscular Dystrophy Sales and Market Share by Type (2013-2018) 13.2.1 Australia Duchenne Muscular Dystrophy Sales by Type (2013-2018) 13.2.2 Australia Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) 13.3 Australia Duchenne Muscular Dystrophy Sales by Application (2013-2018) 13.3.1 Australia Duchenne Muscular Dystrophy Sales by Application (2013-2018) 13.3.2 Australia Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) 13.4 Australia Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Manufacturer (2016-2017) 13.4.1 Australia Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2016-2017) 13.4.2 Australia Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2016-2017) 13.5 Australia Duchenne Muscular Dystrophy Export and Import (2013-2018) 14 Duchenne Muscular Dystrophy Market Forecast (2018-2023) 14.1 Asia-Pacific Duchenne Muscular Dystrophy Sales, Revenue and Growth Rate (2018-2023) 14.2 Duchenne Muscular Dystrophy Market Forecast by Countries/Regions (2018-2023) 14.2.1 China Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) 14.2.2 Japan Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) 14.2.3 Korea Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) 14.2.4 Taiwan Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) 14.2.5 Southeast Asia Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) 14.2.6 India Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) 14.2.7 Australia Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) 14.3 Duchenne Muscular Dystrophy Market Forecast by Type (2018-2023) 14.3.1 Asia-Pacific Duchenne Muscular Dystrophy Sales Forecast by Type (2018-2023) 14.3.2 Asia-Pacific Duchenne Muscular Dystrophy Market Share Forecast by Type (2018-2023) 14.4 Duchenne Muscular Dystrophy Market Forecast by Application (2018-2023) 14.4.1 Asia-Pacific Duchenne Muscular Dystrophy Sales Forecast by Application (2018-2023) 14.4.2 Asia-Pacific Duchenne Muscular Dystrophy Market Share Forecast by Application (2018-2023) 15 Duchenne Muscular Dystrophy Manufacturing Cost Analysis 15.1 Duchenne Muscular Dystrophy Key Raw Materials Analysis 15.1.1 Key Raw Materials 15.1.2 Price Trend of Key Raw Materials 15.1.3 Key Suppliers of Raw Materials 15.1.4 Market Concentration Rate of Raw Materials 15.2 Proportion of Manufacturing Cost Structure 15.2.1 Raw Materials 15.2.2 Labor Cost 15.2.3 Manufacturing Expenses 15.3 Manufacturing Process Analysis of Duchenne Muscular Dystrophy 16 Industrial Chain, Sourcing Strategy and Downstream Buyers 16.1 Duchenne Muscular Dystrophy Industrial Chain Analysis 16.2 Upstream Raw Materials Sourcing 16.3 Raw Materials Sources of Duchenne Muscular Dystrophy Major Manufacturers in 2017 16.4 Downstream Buyers 17 Sales Channel, Distributors, Traders and Dealers 17.1 Sales Channel 17.1.1 Direct Marketing 17.1.2 Indirect Marketing 17.1.3 Marketing Channel Future Trend 17.2 Distributors, Traders and Dealers 18 Research Findings and Conclusion 19 Appendix 19.1 Methodology 19.2 Data Source

List of Tables and Figures Figure Duchenne Muscular Dystrophy Picture Table Product Specifications of Duchenne Muscular Dystrophy Figure Asia-Pacific Sales Market Share of Duchenne Muscular Dystrophy by Types in 2017 Table Types of Duchenne Muscular Dystrophy Figure Deflazacort Picture Figure Prednisone Picture Figure Others Picture Figure Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Applications in 2017 Table Applications of Duchenne Muscular Dystrophy Figure Male Picture Figure Female Picture Figure China Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate (2013-2023) Figure Korea Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate (2013-2023) Figure Japan Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate (2013-2023) Figure Taiwan Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate (2013-2023) Figure Southeast Asia Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate (2013-2023) Figure India Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate (2013-2023) Figure Australia Duchenne Muscular Dystrophy Revenue (Million USD) and Growth Rate (2013-2023) Table PTC Therapeutics Basic Information, Manufacturing Base and Competitors Table PTC Therapeutics Duchenne Muscular Dystrophy Type and Applications Table PTC Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors Table Sarepta Therapeutics Duchenne Muscular Dystrophy Type and Applications Table Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Type and Applications Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table ITALFARMACO Basic Information, Manufacturing Base and Competitors Table ITALFARMACO Duchenne Muscular Dystrophy Type and Applications Table ITALFARMACO Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table BioMarin Basic Information, Manufacturing Base and Competitors Table BioMarin Duchenne Muscular Dystrophy Type and Applications Table BioMarin Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors Table Daiichi Sankyo Duchenne Muscular Dystrophy Type and Applications Table Daiichi Sankyo Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Solid Biosciences Basic Information, Manufacturing Base and Competitors Table Solid Biosciences Duchenne Muscular Dystrophy Type and Applications Table Solid Biosciences Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Summit Therapeutics Basic Information, Manufacturing Base and Competitors Table Summit Therapeutics Duchenne Muscular Dystrophy Type and Applications Table Summit Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table FibroGen Basic Information, Manufacturing Base and Competitors Table FibroGen Duchenne Muscular Dystrophy Type and Applications Table FibroGen Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table NS Pharma Basic Information, Manufacturing Base and Competitors Table NS Pharma Duchenne Muscular Dystrophy Type and Applications Table NS Pharma Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Duchenne Muscular Dystrophy Type and Applications Table Pfizer Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table ReveraGen BioPharma Basic Information, Manufacturing Base and Competitors Table ReveraGen BioPharma Duchenne Muscular Dystrophy Type and Applications Table ReveraGen BioPharma Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Wave Life Basic Information, Manufacturing Base and Competitors Table Wave Life Duchenne Muscular Dystrophy Type and Applications Table Wave Life Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Genethon Basic Information, Manufacturing Base and Competitors Table Genethon Duchenne Muscular Dystrophy Type and Applications Table Genethon Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Santhera Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Santhera Pharmaceuticals Duchenne Muscular Dystrophy Type and Applications Table Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Asia-Pacific Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017) Figure Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016 Figure Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017 Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017) Table Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer (2016-2017) Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016 Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017 Table Asia-Pacific Duchenne Muscular Dystrophy Price by Manufacturers (2016-2017) Figure Top 3 Duchenne Muscular Dystrophy Manufacturer Market Share in 2016 Figure Top 3 Duchenne Muscular Dystrophy Manufacturer Market Share in 2017 Figure Top 6 Duchenne Muscular Dystrophy Manufacturer Market Share in 2016 Figure Top 6 Duchenne Muscular Dystrophy Manufacturer Market Share in 2017 Figure Asia-Pacific Duchenne Muscular Dystrophy Sales and Growth (2013-2018) Table Asia-Pacific Duchenne Muscular Dystrophy Sales by Countries/Regions (2013-2018) Table Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Countries (2013-2018) Figure Asia-Pacific 2013 Duchenne Muscular Dystrophy Sales Market Share by Countries Figure Asia-Pacific 2017 Duchenne Muscular Dystrophy Sales Market Share by Countries Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018) Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Countries (2013-2018) Table Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific 2013 Duchenne Muscular Dystrophy Revenue Market Share by Countries Figure Asia-Pacific 2016 Duchenne Muscular Dystrophy Revenue Market Share by Countries Table Asia-Pacific Duchenne Muscular Dystrophy Sales by Type (2013-2018) Table Asia-Pacific Duchenne Muscular Dystrophy Sales Share by Type (2013-2018) Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Type (2013-2018) Table Asia-Pacific Duchenne Muscular Dystrophy Revenue Share by Type (2013-2018) Figure Asia-Pacific Deflazacort Sales Growth (2013-2018) Figure Asia-Pacific Deflazacort Price (2013-2018) Figure Asia-Pacific Prednisone Sales Growth (2013-2018) Figure Asia-Pacific Prednisone Price (2013-2018) Figure Asia-Pacific Others Sales Growth (2013-2018) Figure Asia-Pacific Others Price (2013-2018) Table Asia-Pacific Duchenne Muscular Dystrophy Sales by Application (2013-2018) Table Asia-Pacific Duchenne Muscular Dystrophy Sales Share by Application (2013-2018) Figure Asia-Pacific Male Sales Growth (2013-2018) Figure Asia-Pacific Female Sales Growth (2013-2018) Figure China Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018) Figure China Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018) Table China Duchenne Muscular Dystrophy Sales by Type (2013-2018) Table China Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) Table China Duchenne Muscular Dystrophy Sales by Application (2013-2018) Table China Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) Table China Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017) Figure China Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016 Figure China Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017 Table China Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017) Figure China Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016 Figure China Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017 Table China Duchenne Muscular Dystrophy Export and Import (2013-2018) Figure Japan Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018) Figure Japan Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018) Table Japan Duchenne Muscular Dystrophy Sales by Type (2013-2018) Table Japan Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) Table Japan Duchenne Muscular Dystrophy Sales by Application (2013-2018) Table Japan Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) Table Japan Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017) Figure Japan Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016 Figure Japan Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017 Table Japan Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017) Figure Japan Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016 Figure Japan Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017 Table Japan Duchenne Muscular Dystrophy Export and Import (2013-2018) Figure Korea Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018) Figure Korea Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018) Table Korea Duchenne Muscular Dystrophy Sales by Type (2013-2018) Table Korea Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) Table Korea Duchenne Muscular Dystrophy Sales by Application (2013-2018) Table Korea Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) Table Korea Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017) Figure Korea Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016 Figure Korea Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017 Table Korea Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017) Figure Korea Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016 Figure Korea Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017 Table Korea Duchenne Muscular Dystrophy Export and Import (2013-2018) Figure Taiwan Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018) Figure Taiwan Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018) Table Taiwan Duchenne Muscular Dystrophy Sales by Type (2013-2018) Table Taiwan Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) Table Taiwan Duchenne Muscular Dystrophy Sales by Application (2013-2018) Table Taiwan Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) Table Taiwan Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017) Figure Taiwan Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016 Figure Taiwan Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017 Table Taiwan Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017) Figure Taiwan Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016 Figure Taiwan Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017 Table Taiwan Duchenne Muscular Dystrophy Export and Import (2013-2018) Figure Southeast Asia Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018) Figure Southeast Asia Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018) Table Southeast Asia Duchenne Muscular Dystrophy Sales by Type (2013-2018) Table Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) Table Southeast Asia Duchenne Muscular Dystrophy Sales by Application (2013-2018) Table Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) Table Southeast Asia Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017) Figure Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016 Figure Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017 Table Southeast Asia Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017) Figure Southeast Asia Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016 Figure Southeast Asia Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017 Table Southeast Asia Duchenne Muscular Dystrophy Export and Import (2013-2018) Figure India Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018) Figure India Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018) Table India Duchenne Muscular Dystrophy Sales by Type (2013-2018) Table India Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) Table India Duchenne Muscular Dystrophy Sales by Application (2013-2018) Table India Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) Table India Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017) Figure India Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016 Figure India Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017 Table India Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017) Figure India Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016 Figure India Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017 Table India Duchenne Muscular Dystrophy Export and Import (2013-2018) Figure Australia Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018) Figure Australia Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018) Table Australia Duchenne Muscular Dystrophy Sales by Type (2013-2018) Table Australia Duchenne Muscular Dystrophy Sales Market Share by Type (2013-2018) Table Australia Duchenne Muscular Dystrophy Sales by Application (2013-2018) Table Australia Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018) Table Australia Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017) Figure Australia Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016 Figure Australia Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017 Table Australia Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017) Figure Australia Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016 Figure Australia Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017 Table Australia Duchenne Muscular Dystrophy Export and Import (2013-2018) Figure Asia-Pacific Duchenne Muscular Dystrophy Sales, Revenue and Growth Rate (2018-2023) Table Asia-Pacific Duchenne Muscular Dystrophy Sales Forecast by Countries/Regions (2018-2023) Table Asia-Pacific Duchenne Muscular Dystrophy Market Share Forecast by Countries/Regions (2018-2023) Figure China Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) Figure Japan Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) Figure Korea Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) Figure Taiwan Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) Figure Southeast Asia Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) Figure India Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) Figure Australia Duchenne Muscular Dystrophy Sales and Growth Rate Forecast (2018-2023) Table Asia-Pacific Duchenne Muscular Dystrophy Sales Forecast by Type (2018-2023) Table Asia-Pacific Duchenne Muscular Dystrophy Market Share Forecast by Type (2018-2023) Table Asia-Pacific Duchenne Muscular Dystrophy Sales Forecast by Application (2018-2023) Table Asia-Pacific Duchenne Muscular Dystrophy Market Share Forecast by Application (2018-2023) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Duchenne Muscular Dystrophy Figure Manufacturing Process Analysis of Duchenne Muscular Dystrophy Figure Duchenne Muscular Dystrophy Industrial Chain Analysis Table Raw Materials Sources of Duchenne Muscular Dystrophy Major Manufacturers in 2017 Table Major Buyers of Duchenne Muscular Dystrophy Table Distributors/Traders/ Dealers List